Age-related macular degeneration or ARMD: turn to intravitreal injections of anti-VEGF drugs
For some years, age-related macular degeneration has been treated with intravitreal anti-VEGF drug injections that block or inhibit the proliferation of abnormal blood vessels. This therapy is carried out in the operating theatre; the drug is injected in the vitreous humour after instilling some anaesthetic drops. The whole process lasts a few minutes, therefore the patient can go home after the operation. The functional results are satisfying, the illness is put to an end and in the luckiest cases there is even partial recovery of vision.
Discover a new treatment for macular degeneration: IOL-Vip Revolution